A detailed history of Financial Council Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Council Asset Management Inc holds 6,871 shares of ABT stock, worth $716,095. This represents 0.46% of its overall portfolio holdings.

Number of Shares
6,871
Previous 6,871 -0.0%
Holding current value
$716,095
Previous $756,000 3.17%
% of portfolio
0.46%
Previous 0.51%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $3,612 - $4,237
-38 Reduced 0.55%
6,871 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $108,371 - $125,473
1,120 Added 19.35%
6,909 $669,000
Q1 2022

May 02, 2022

BUY
$114.02 - $139.04 $129,298 - $157,671
1,134 Added 24.36%
5,789 $685,000
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $1,732 - $2,121
15 Added 0.32%
4,655 $655,000
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $541,302 - $598,838
4,640 New
4,640 $548,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $183B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Council Asset Management Inc Portfolio

Follow Financial Council Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Council Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Council Asset Management Inc with notifications on news.